Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-93.48	25.54	391.67
Graham Fair Price	171.34	10.01	3.69
PEG	-95.40	< 0.005	0.17
Price/Book	-35.78	0.43	0.67
Price/Cash Flow	11.29	34.50	31.00
Prices/Earnings	-82.23	3.94	-22.18
Price/Sales	47.30	17.18	11.66
Price/FCF	11.29	34.50	31.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-21.34	0.57	0.73
Operating Margin	2277.06	1.39	0.06
ROA	412.13	0.02	< 0.005
ROE	< 0.005	0.03	261.51
ROIC	0.01	< 0.005	-85.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	-21.12
Dividends QOQ	-0.14	0.18	27.26
EBIT QOQ	-0.92	13.92	1410.27
EPS QOQ	-1.29	5.00	286.55
FCF QOQ	-0.16	-0.17	-2.70
Revenue QOQ	6.34	-0.37	-94.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	15.93	21.74	36.50
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.42	0.33	-20.13
Quick Ratio	0.87	0.71	-17.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	8.96	12.79	42.71
Cash	0.24	0.13	-45.50
Capex	0.00	0.00	0.00
Free Cash Flow	0.19	0.16	-17.64
Revenue	0.51	0.32	-37.78
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.63	0.72	14.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	192.40	13.19	-93.15
Naive Interpretation	Member

06 - Financial Health · Bad

Rating